Tobacco Policy/Regulatory Factors - Prevention Summary Table
Only one measure per topic is displayed in the summary table. A complete set of measures, where they exist, can be found by following the More Information link in the table below.
![]() |
green - headed in the right direction |
![]() |
red - headed in the wrong direction |
![]() |
black - stable or non-significant change (NSC) |
![]() |
purple - indeterminate |
![]() |
blue - Healthy People 2030 target |
Measure Name | Tobacco Company Marketing Expenditures | Medicaid Coverage of Tobacco Dependence Treatments |
---|---|---|
Year Range | 1970-2020 | 1990-2010 |
Measure |
Combined cigarette annual advertising and promotional expenditures by the parent companies of the major manufacturers of cigarettes sold in the U.S., adjusted, as reported by manufacturers to the U.S. Federal Trade Commission. Combined smokeless tobacco annual advertising and promotional expenditures by the parent companies of the major manufacturers of smokeless tobacco products in the U.S., adjusted, as reported by manufacturers to the U.S. Federal Trade Commission. |
The number of states that provide coverage under Medicaid for any evidence-based tobacco dependence treatment (pharmacotherapy or counseling), either to their entire Medicaid population or to only pregnant women. The number of states that provide coverage under Medicaid for individual or group tobacco cessation counseling. 1 |
Recent Summary Trend | Falling | Rising |
Recent Summary Trend Year Range | 2016-2020 | 2006-2010 |
Desired Direction | Falling | Rising |
Summary Graph |
![]() |
![]() |
Trends and Most Recent Estimates | In 2020, adjusted combined annual expenditures for cigarette advertising and promotion was $7.8 billion. | In 2010, all 51 Medicaid programs provided coverage for at least one tobacco-dependence treatment for at least some segment of their Medicaid eligible population. |
Healthy People 2030 Target | No Healthy People Target for this measure. | No Healthy People Target for this measure. |
More Information | Tobacco Company Marketing Expenditures | Medicaid Coverage of Tobacco Dependence Treatments |
Last Updated | April 2022 | April 2022 |
Measure Name | Tobacco Company Marketing Expenditures |
---|---|
Year Range | 1970-2020 |
Measure |
Combined cigarette annual advertising and promotional expenditures by the parent companies of the major manufacturers of cigarettes sold in the U.S., adjusted, as reported by manufacturers to the U.S. Federal Trade Commission. Combined smokeless tobacco annual advertising and promotional expenditures by the parent companies of the major manufacturers of smokeless tobacco products in the U.S., adjusted, as reported by manufacturers to the U.S. Federal Trade Commission. |
Recent Summary Trend | Falling |
Recent Summary Trend Year Range | 2016-2020 |
Desired Direction | Falling |
Summary Graph |
![]() |
Trends and Most Recent Estimates | In 2020, adjusted combined annual expenditures for cigarette advertising and promotion was $7.8 billion. |
Healthy People 2020 Target | No Healthy People Target for this measure. |
More Information | Tobacco Company Marketing Expenditures |
Measure Name | Medicaid Coverage of Tobacco Dependence Treatments |
---|---|
Year Range | 1990-2010 |
Measure |
The number of states that provide coverage under Medicaid for any evidence-based tobacco dependence treatment (pharmacotherapy or counseling), either to their entire Medicaid population or to only pregnant women. The number of states that provide coverage under Medicaid for individual or group tobacco cessation counseling. 1 |
Recent Summary Trend | Rising |
Recent Summary Trend Year Range | 2006-2010 |
Desired Direction | Rising |
Summary Graph |
![]() |
Trends and Most Recent Estimates | In 2010, all 51 Medicaid programs provided coverage for at least one tobacco-dependence treatment for at least some segment of their Medicaid eligible population. |
Healthy People 2020 Target | No Healthy People Target for this measure. |
More Information | Medicaid Coverage of Tobacco Dependence Treatments |